Table 1.
Clinical, laboratory, echocardiographic, and angiographic characteristics of the study population
| HR-G (n=52) | LR-G (n=81) | P value | |
|---|---|---|---|
| Age (years) | 78.8±6.9 | 78.6±7.8 | 0.369 |
| Female gender, n (%) | 29 (55.8) | 43 (53.1) | 0.451 |
| STS score (%) | 13.3±4.3 | 14.6±6.7 | 0.472 |
| Logistic EuroSCORE (%) | 29.4 (15.9-38.2) | 24.7 (14.8-35.3) | 0.093 |
| AKIN, n (%) | 22 (42.3) | 8 (9.9) | <0.001 |
| Mortality, n (%) | 5 (9.6) | 3 (3.7) | 0.153 |
| Hemoglobin (g/dl) | 12.3±1.6 | 12.4±1.8 | 0.860 |
| RBC transfusion, n (%) | 15 (28.8) | 20 (24.7) | 0.785 |
| Left ventricle ejection fraction (%) | 41.9±10.4 | 42.6±11.1 | 0.726 |
| NT-pro BNP (pg/ml) | 4188±1388 | 3811±1258 | 0.640 |
| AVA (cm2) | 0.65±0.19 | 0.64±0.21 | 0.506 |
| Mean gradient (mmHg) | 49.1±12.9 | 50.2±10.6 | 0.590 |
| SBP (mmHg) | 120.1±9.8 | 132.7±7.3 | <0.001 |
| DBP (mmHg) | 57.4±8.1 | 69.6±9.4 | <0.001 |
| mAP (mmHg) | 78.1±9.7 | 90.5±8.3 | <0.001 |
| CVP (mmHg) | 13.2±2.9 | 10.9±2.5 | <0.001 |
| mPP (mmHg) | 64.1±7.1 | 79.7±5.3 | <0.001 |
| Creatinine (mg/dl) | 1.06±0.32 | 1.01±0.29 | 0.642 |
| eGFR (ml/dk/1.73 m2) | 60.15±14.6 | 62.69±16.7 | 0.348 |
| Diuretic, n (%) | 10 (19.2) | 13 (16.0) | 0.443 |
| RAAS blocker, n (%) | 24 (46.2) | 40 (49.4) | 0.214 |
| Beta-blocker, n (%) | 29 (55.7) | 50 (61.7) | 0.494 |
| Amount of contrast (ml) | 147 (115-245) | 140.5 (120-212) | 0.065 |
| AR after TAVI (≥ grade II) | 6 (11.5) | 10 (12.3) | 0.646 |
| Number of rapid pacing | 2.9±0.6 | 2.7±0.4 | 0.348 |
| Rapid pacing duration (second) | 41 (25-63) | 40 (21-55) | 0.642 |
| Previous CABG, n (%) | 10 (19.2) | 13 (16.0) | 0.443 |
| Previous PCI, n (%) | 9 (17.3) | 19 (23.8) | 0.254 |
| Diabetes mellitus, n (%) | 19 (36.5) | 27 (33.3) | 0.422 |
| Hypertension, n (%) | 21 (40.6) | 34 (41.9) | 0.908 |
| Hypercholesterolemia, n (%) | 20 (38.5) | 40 (49.4) | 0.145 |
| COPD, n (%) | 20 (38.5) | 26 (32,1) | 0.285 |
| CAD, n (%) | 25 (48.1) | 40 (49.4) | 0.512 |
| Intensive care unit (days) | 2 (1.3-3.2) | 1.5 (1.1-2.1) | 0.022 |
| Hospital duration (days) | 5 (3.5-6.2) | 4 (3.3-5.8) | 0.027 |
Values are number (%), mean ± standard deviation, or median [25th, 75th percentiles].
AKIN=acute kidney injury; AR=aortic regurgitation; AVA=aortic valve area; BNP=b-type natriuretic peptide; CABG=coronary artery bypass graft; CAD=coronary artery disease; COPD=chronic obstructive pulmonary disease; CVP=central venous pressure; DBP=diastolic blood pressure; eGFR=estimated glomerular filtration rate; HR-G=High-risk group; LR-G=Low-risk group; mAP=mean arterial pressure; mPP=mean perfusion pressure; NT=N-terminal; PCI=percutaneous coronary intervention; RAAS=renin-angiotensin-aldosterone system; RBC=red blood cell; SBP=systolic blood pressure; STS=Society of Thoracic Surgeons; TAVI=transcatheter aortic valve implantation